The Single-Cell Center Würzburg is a joint competence center of the Helmholtz Institute for RNA-based Infection Research (HIRI) with the Faculty of Medicine of the Julius-Maximilians-Universität (JMU), the University Hospital Würzburg (UKW), the Fraunhofer Translational Center for Regenerative Therapies (TLZ-RT), and the Max Planck Research Group at the Würzburg Institute of Systems Immunology (WüSI).
The center’s objective is to analyze and understand diseases at the level of individual cells. In the future, this will enable the earliest possible and most reliable prediction of a disease and how it can be treated in the best possible way.
Starting from infection research, the Würzburg Single-Cell Center will also investigate cancer, neurodegenerative disorders or cardiovascular diseases at the single-cell level. The broad method spectrum of RNA sequencing technologies is to be rapidly enhanced in this context.
The Single-Cell Center is funded by the Bavarian State Ministry of Economic Affairs, Regional Development and Energy. Its goal is to combine scientific, clinical and methodological expertise in Würzburg. In the medium run, the competence center is intended to develop into a strong service unit with the participation of the JMU and the UKW.
Prof Antoine-Emmanuel Saliba.
HIRI + JMU + UKW + WÜSI + TLZ-RT.
Seed funding from Bavarian State Ministry of Economic Affairs, Regional Development and Energy.
Direct link from basic research to medicine.
Partnership with strong research institutions.
Campus broadly positioned in life sciences and physics.
Benefits & Goals
Pooling scientific, clinical and methodological expertise relevant to innovative single-cell research at the site.
Strong service unit for personalized medicine of the future.
Let's take a step forward
Interested in our work?